Analyst consensus rating
Pfizer Analyst Rating: Buy
PFE is rated Buy by 26 analysts with a $28.61 target. As of 2026-08-21.
Direct answer
Pfizer's consensus rating is Buy.
26 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $28.61.
Forecast evidence checked August 21, 2026.
Get free Pfizer email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $27.79
- Average price target
- $28.61
- High price target
- $35.75
- Low price target
- $25.00
- Low target gap
- -10%
- Target upside
- +2.9%
- High target gap
- +28.6%
- Target range width
- 38.7%
- Consensus rating
- Buy
- Analysts
- 26
- Evidence date
- August 21, 2026
- Valid through
- August 28, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Pfizer?
Pfizer has a verified Buy consensus. The same dataset has an average price target of $28.61.
How far are Pfizer's low and high targets from the recorded price?
The low target implies -10%, while the high target implies +28.6%.
How many analysts are included in Pfizer's consensus?
The verified consensus includes 26 analysts.
How is Pfizer's target upside or downside calculated?
The average target of $28.61 is divided by the recorded price of $27.79, then one is subtracted to produce +2.9%. This does not guarantee a future return.
When was Pfizer's analyst forecast verified?
The data was verified on 2026-08-21. The dataset is valid through 2026-08-28.